Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel∗

ABSTRACT:

SUBMITTER: Ahmed N 

PROVIDER: S-EPMC11568755 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature